These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18412925)

  • 1. ENHANCE: food for the ostriches.
    Jackson G
    Int J Clin Pract; 2008 May; 62(5):667-8. PubMed ID: 18412925
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ
    N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract]   [Full Text] [Related]  

  • 4. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Connor WE
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Steinberg D
    N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 7. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
    Brown BG; Taylor AJ
    N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesterol lowering and ezetimibe.
    Drazen JM; Jarcho JA; Morrissey S; Curfman GD
    N Engl J Med; 2008 Apr; 358(14):1507-8. PubMed ID: 18376001
    [No Abstract]   [Full Text] [Related]  

  • 9. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlling LDL cholesterol from 2 sides. "I have never seen such low LDL values"].
    MMW Fortschr Med; 2003 May; 145(20):59. PubMed ID: 12822234
    [No Abstract]   [Full Text] [Related]  

  • 11. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
    Michałek A
    Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
    [No Abstract]   [Full Text] [Related]  

  • 12. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kaye T
    N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dual lipid control without anti-atherosclerosis effect].
    Einecke D
    MMW Fortschr Med; 2008 Apr; 150(16):18, 20. PubMed ID: 18557109
    [No Abstract]   [Full Text] [Related]  

  • 15. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Blake JA
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
    MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
    [No Abstract]   [Full Text] [Related]  

  • 19. Ezetimibe--an update.
    Drug Ther Bull; 2009 Aug; 47(8):91-5. PubMed ID: 19654419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources].
    MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.